Merck KGaA

Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2015, Merck generated sales of € 12.8 billion in 66 countries. Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.
Company Growth (employees)
Darmstadt, DE
Size (employees)
51,480 (est)+2%
Merck KGaA is headquartered in Darmstadt, DE

Key People/Management at Merck KGaA

Stefan Oschmann

Stefan Oschmann

Chairman of the Executive Board | CEO
Udit Batra

Udit Batra

Member of the Executive Board | CEO Life Science
Kai Beckmann

Kai Beckmann

Member of the Executive Board | CEO Performance Materials
Walter Galinat

Walter Galinat

Member of the Executive Board
Belén Garijo

Belén Garijo

Member of the Executive Board | CEO Healthcare
Marcus Kuhnert

Marcus Kuhnert

Member of the Executive Board | Chief Financial Officer

Merck KGaA Office Locations

Merck KGaA has an office in Darmstadt
Darmstadt, DE (HQ)
250 Frankfurter Str.
Show all (1)

Merck KGaA Financials and Metrics

Merck KGaA Financials

Merck KGaA's revenue was reported to be €12.8 b in FY, 2015 which is a 13% increase from the previous period.

Revenue (FY, 2015)

12.8 b

Revenue growth (FY, 2014 - FY, 2015), %


Gross profit (FY, 2015)

8.8 b

Gross profit margin (FY, 2015), %


Net income (FY, 2015)

1.1 b

EBIT (FY, 2015)

1.8 b

Market capitalization (30-Oct-2017)

40 b

Closing share price (30-Oct-2017)


Cash (31-Dec-2015)

832.2 m


48.7 b
Merck KGaA's current market capitalization is €40 b.
EURFY, 2014FY, 2015


11.4 b12.8 b

Revenue growth, %


Cost of goods sold

3.5 b4.1 b

Gross profit

7.8 b8.8 b
EURY, 2014Y, 2015


2.9 b832.2 m

Total Assets

26 b38 b

Total Debt

3.6 b9.6 b

Total Liabilities

14.2 b25.2 b
EURFY, 2014FY, 2015

Cash From Operating Activities

2.7 b2.2 b
Y, 2015


26.4 x


22.2 x
Show all financial metrics

Merck KGaA Market Value History

Merck KGaA Revenue Breakdown

Merck KGaA's Web-traffic and Trends

Merck KGaA Online and Social Media Presence

Merck KGaA News and Updates

Merck KGaA puts devices to work against diabetes in Blue Mesa digital program

​​​​​​​The latest entrant into the digital diabetes arena is Merck KGaA. The Glucophage maker has teamed with digital healthcare provider Blue Mesa Health to target people recently diagnosed with prediabetes and help prevent their advancing to Type 2.

In depth information: Microbial Identification Service Market (Liofilchem, Merck KGaA, bioMrieux) Evolving Trends, Future Profitability & Development

Microbial Identification Service Market Latest Developments by Type, by End-Users/Application, by Region - Forecast and Business Outlook Posted via Industry Today. Follow us on Twitter @IndustryToday

Merck KGaA Company Life and Culture

You may also be interested in